Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adrenomedullin provocation in post-traumatic headache
NCT07059546Recruiting
- Sponsor
- Dansk Hovedpinecenter
- Start
- Aug 2025
- Primary completion
- May 2028
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in post-traumatic headache (PTH) comparing Adrenomedullin with Placebo (2 arms). Primary endpoint: Incidence of headache with migraine-like features at 12 hours. Started Aug 2025; status: recruiting.
02
Drugs
fispemifene
03
Conditions
post-traumatic headache (PTH)
Beyond the preview
Go deeper on NCT07059546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07059546.